Fundraising Fox
Velsera
Founded 2023 · 427 employees on LinkedIn · 4 known investors
Find your way into Velsera
Sign up to see every warm intro you have to Velsera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Velsera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Velsera provides integrated software and expert services that turn complex biomedical and genomic data into usable insights for precision medicine, drug discovery, diagnostics development, and genetic testing. It serves organizations in the life sciences and healthcare sectors working on discovery, diagnostics, and regulatory navigation.
Founders & leadership
JC
Jamie CoffinChief Executive OfficerJamie Coffin is Chief Executive Officer of Velsera, a provider of biomedical and genomic data analytics software and services for precision medicine and drug discovery. With over 20 years in healthcare and life sciences, Coffin has held leadership roles in strategy and team management across biomanufacturing, genomics, and informatics domains.
PG
Pavel GongoraChief Strategy and Product OfficerPavel Gongora is Chief Strategy and Product Officer at Velsera, a bioinformatics software and services company focused on precision medicine and drug discovery. He has approximately 20 years of experience in life sciences and healthcare, including prior work as an Associate Partner at McKinsey, and holds a background in medicine.
MK
Mike KlingChief Technology Officer
LC
Lou ClarkeChief People OfficerLou Clarke is Chief People Officer at Velsera, having previously led HR and organizational transformation initiatives across technology, healthcare, and professional services organizations spanning EMEA, APAC, and the Americas. Clarke holds a CIPD Level 7 qualification in HR Management.
BZ
Becky ZimmermanSVP Clinical Product and Chief Clinical OfficerShe brings expertise in clinical molecular genetics, genetic diagnostic testing, newborn screening, and prenatal genetics, among other specialties in genetics-based diagnostics.
Investors · 4
Health Catalyst Capitallisted by Health Catalyst CapitalNew York
How we know: Health Catalyst Capital's portfolio page · Not right? Tell us
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us
Summa EquityreportedStockholm
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Velsera do?
- Velsera provides integrated software and expert services that turn complex biomedical and genomic data into usable insights for precision medicine, drug discovery, diagnostics development, and genetic testing. It serves organizations in the life sciences and healthcare sectors working on discovery, diagnostics, and regulatory navigation.
- Who are Velsera's investors?
- Velsera's investors include Health Catalyst Capital, OrbiMed, SJF Ventures, Summa Equity.